Abstract
There is good evidence supporting that people with fibromyalgia syndrome (FMS) exhibit central sensitization. The role of peripheral nociception is under debate in FMS. It seems that widespread pain experienced in FMS is considered multiple regional pains; therefore, several authors proposed that muscles play a relevant role in FMS. Trigger points (TrPs) have long been a contentious issue in relation to FMS. Preliminary evidence reported that the overall spontaneous pain is reproduced by referred pain from active TrPs, suggesting that FMS pain is largely composed of pain arising, at least partially, from TrPs. Finally, there is preliminary evidence suggesting that management of TrPs is able to modulate the CNS and is effective for reducing pain in FMS, although results are conflicting and future studies are clearly needed.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 . Fibromyalgia: a clinical review. JAMA 311, 1547–1555 (2014).
- 2 . Worldwide epidemiology of fibromyalgia. Curr. Pain Headache Rep. 17, 356 (2013).
- 3 Prevalence of fibromyalgia: a survey in five European countries. Semin. Arthritis Rheum. 39, 448–453 (2010).
- 4 Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 58, 26–35 (2008).
- 5 . Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain. Curr. Rheumatol. Rep. 12, 448–454 (2010).
- 6 Small fibre pathology in patients with fibromyalgia syndrome. Brain 136, 1857–1867 (2013).
- 7 . Neural and psychosocial mechanisms of pain sensitivity in fibromyalgia. Pain Manag. Nurs. 15, 530–538 (2014). • Discusses the neurophysiological aspects of pain sensitivity in people with fibromyalgia syndrome (FMS).
- 8 . Altered processing of pain-related information in patients with fibromyalgia. Eur. J. Pain 9, 293–303 (2005).
- 9 Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 48, 1420–1429 (2003).
- 10 . Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 105, 403–413 (2003).
- 11 . Mechanisms of disease: pain in fibromyalgia syndrome. Nat. Clin. Pract. Rheumatol. 2, 90–98 (2006).
- 12 . Central mechanisms in the maintenance of chronic widespread non-inflammatory muscle pain. Curr. Pain Headache Rep. 12, 338–343 (2008).
- 13 . Neuronal plasticity: increasing the gain in pain. Science 288, 1765–1769 (2000).
- 14 . Chronic pain may change the structure of the brain. Pain 137, 7–15 (2008).
- 15 . Central sensitization in fibromyalgia? A systematic review of structural and functional brain MRI. Semin. Arthritis Rheum. 44, 68–75 (2014). •• This review confirms the presence of common structural and functional changes in the brain in people with FMS.
- 16 . Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 206, 97–99 (1965).
- 17 . Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 145, 96–104 (2009).
- 18 . Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur. J. Pain 15, 61–69 (2011). •• This clinical trial supports the role of peripheral nociception for the treatment of individuals with FMS.
- 19 . Peripheral pain mechanisms in chronic widespread pain. Best Pract. Res. Clin. Rheumatol. 25, 155–164 (2011).
- 20 . Response behaviour of cat dorsal horn neurones receiving input from skeletal muscle and other deep somatic tissues. J. Physiol. 426, 265–280 (1990).
- 21 . Convergent inputs from articular, cutaneous and muscle receptors onto ascending tract cells in the cat spinal cord. Exp. Brain Res. 66, 479–488 (1987).
- 22 . Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J. Physiol. 356, 443–458 (1984).
- 23 . Fibromyalgia: present to future. Curr. Rheumatol. Rep. 7, 371–376 (2005).
- 24 . Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 124, 242–263 (2006).
- 25 . Muscle Pain: Understanding the Mechanisms. Springer-Verlag, Berlin, Germany (2010).
- 26 . The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin. J. Pain 17, 2–10 (2001).
- 27 . Perceptual distortions of the human body image produced by local anaesthesia, pain and cutaneous stimulation. J. Physiol. 15, 609–616 (1999).
- 28 . Fundamental of muscle pain: referred pain and deep tissue hyperalgesia. Scand. J. Rheumatol. 122, 1–43 (2006).
- 29 . Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J. Pain 5, 338–343 (2004).
- 30 . Overall fibromyalgia pain is predicted by ratings of local pain and pain related negative affect: possible role of peripheral tissues. Rheumatology 45, 1409–1415 (2006).
- 31 . A review of myofascial pain and fibromyalgia: factors that promote their persistence. Acup. Med. 23, 121–134 (2005).
- 32 . Fibromyalgia, myofascial pain, tender points and trigger points: splitting or lumping? Arthritis Res. Ther. 13, 117 (2011). • This letter opens the discussion about trigger and tender points in fibromyalgia.
- 33 . Fibromyalgia and myofascial pain syndrome: a dilemma. Indian J. Anaesth. 53, 575–581 (2009).
- 34 Signs and symptoms of the myofascial pain syndrome: a national survey of pain management providers. Clin. J. Pain 16, 64–72 (2000).
- 35 The American College of Rheumatology 1990 criteria for classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 33, 160–170 (1990).
- 36 The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 62, 600–610 (2010).
- 37 . Localized or widespread musculoskeletal pain: does it matter? Pain 138, 41–46 (2008).
- 38 Central hyperexcitability in fibromyalgia. J. Musculoskeletal Pain 7(1/2), 261–271 (1999).
- 39 . Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period. Rheumatol. Int. 27, 1011–1018 (2007).
- 40 . What do tender points measure? Influence of distress on 4 measures of tenderness. J. Rheumatol. 30, 567–574 (2003).
- 41 Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study. Arthritis Rheum. 61, 732–739 (2009).
- 42 Tender points are not sites of ongoing inflammation – in vivo evidence in patients with chronic tension-type headache. Cephalalgia 23, 109–116 (2003).
- 43 . Sono-myography and sono-myoelastrography of the tender points of women with fibromyalgia. Ultrasound Med. Biol. 39, 1951–1957 (2013). •• Shows no structural changes in tender points in subjects with FMS.
- 44 . Myofascial Pain and Dysfunction: The Trigger Point Manual Volume 1 (2nd Edition). Williams & Wilkins, Baltimore, MD, USA (1999).
- 45 . An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J. Appl. Physiol. 99, 1977–1984 (2005).
- 46 Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch. Phys. Med. Rehabil. 89, 16–23 (2008).
- 47 . Nociceptive and non-nociceptive hypersensitivity at latent myofascial trigger points. Clin. J. Pain 25, 132–137 (2009).
- 48 Ischemic compression block attenuates mechanical hyperalgesia evoked from latent myofascial trigger point. Exp. Brain Res. 202, 265–267 (2010).
- 49 . The spinal cord connections of the myofascial trigger spots. Eur. J. Pain 11, 624–634 (2007).
- 50 . Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J. Pain 11, 1348–1355 (2010).
- 51 . Capsaicin-induced central sensitization evokes segmental increases in trigger point sensitivity in humans. J. Pain 11, 636–643 (2010).
- 52 . Sympathetic facilitation of hyperalgesia evoked from myofascial tender and trigger points in patients with unilateral shoulder pain. Clin. Neurophysiol. 117, 1545–1550 (2006).
- 53 . Assessment of myofascial trigger points using ultrasound. Am. J. Phys. Med. Rehabil. 95, 72–78 (2016).
- 54 . Mechanisms of muscle pain: significance of trigger points and tender points. Z. Rheumatol. 67, 653–657 (2008).
- 55 The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J. Rheumatol. 19, 944–951 (1992).
- 56 . Primary fibromyalgia: a clinical and laboratory study of 55 patients. Scand. J. Rheumatol. 15, 340–347 (1996).
- 57 . Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain 147, 233–240 (2009).
- 58 . Characteristics of referred muscle pain to the head from active trigger points in women with myofascial temporo-mandibular pain and fibromyalgia syndrome. J. Headache Pain 13, 625–637 (2012).
- 59 . The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J. Pain 11, 644–651 (2010). •• This is the first controlled study demonstrating that the tender point sites used for diagnosis of FMS are trigger point areas.
- 60 . Reproduction of overall spontaneous pain pattern by manual stimulation of active myofascial trigger points in fibromyalgia patients. Arthritis Res. Ther. 13, R48 (2011). •• This is the first study demonstrating that the overall pain pattern of individuals with FMS can be reproducible with trigger point referred pain areas.
- 61 . Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. Clin. J. Pain 27, 405–413 (2011).
- 62 Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 52, 3670–3674 (2005).
- 63 . Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J. Pain 11, 1348–1355 (2010).
- 64 . Central representation of hyperalgesia from myofascial trigger point. Neuroimage 39, 1299–1306 (2008).
- 65 . Prevalence of myofascial trigger points in fibromyalgia: the overlap of two common problems. Curr. Pain Headache Rep. 14, 339–345 (2010).
- 66 . Latent myofascial trigger points are associated with an increased intramuscular electromyographic activity during synergistic muscle activation. J. Pain 15, 181–187 (2014).
- 67 . Effectiveness of different styles of massage therapy in fibromyalgia: a systematic review and meta-analysis. Man Ther. 20, 257–264 (2015).
- 68 . Myofascial pain syndrome and its suggested role in the pathogenesis and treatment of fibromyalgia syndrome. Curr. Pain Headache Rep. 6, 274–283 (2002).
- 69 . Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr. Pharm. Des. 12, 23–27 (2006).
- 70 . Effects of treatment of myofascial trigger points on the pain of fibromyalgia. Curr. Pain Headache Rep. 15, 393–399 (2011). • Discusses the role of trigger point treatment in the management of people with FMS.
- 71 . Chronic whiplash and central sensitization: an evaluation of the role of a myofascial trigger points in pain modulation. J. Brachial. Plex. Peripher. Nerve Inj. 4, 2 (2009).
- 72 . Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch. Phys. Med. Rehabil. 77, 1161–1166 (1996).
- 73 . Short-term improvement following dry needle stimulation of tender points in fibromyalgia. Rheumatol. Int. 34, 861–866 (2014).